Please read our student and staff community guidance on COVID-19
Skip to main content Skip to navigation

Licensing Opportunities available from Warwick Ventures

biology logo Chemistry logo Computing logo Engineering logo Medicine logo Physics logo
Biology Chemistry Computing Engineering Medicine Physics

These pages contain details of the technologies currently available to licence from Warwick Ventures.
If you would like more details of any of these technologies, please contact the relevant Business Development
Manager.

New technologies are added regularly, so do please register your interest and we will send through details of
opportunities as they are published. You can also use the RSS feed on the Licensing Opportunities page to
keep up to date.


Show all news items

Rapid diagnostic test for SARS-CoV-2

image

Rapid COVID-19 diagnosis using glycan-functionalised lateral flow device

Warwick Ventures has available for licence, investment or co-development a new, patent-pending method for the rapid identification of the SARS-CoV-2 virus which causes Covid-19.

The new method delivers a visual readout within 30 minutes and requires no specialist training or lab equipment to complete.

More details: Rapid diagnostic test for SARS-CoV-2

Contact: Dr James Lapworth, Warwick Ventures email: j.lapworth@warwick.ac.uk

Tue 16 Jun 2020, 13:51 | Tags: Life Sciences and Biotechnology, Diagnostic